Includes policies and procedures for responding to students having mental health crises in a manner that does not include contacting law enforcement unless implied or direct threats of violence or other criminal activity is involved in school safety plans.
This bill prohibits the sale of medical adhesives and bandages containing PFAS (perfluoroalkyl and polyfluoroalkyl substances) in New York State after December 31, 2026. It directly affects manufacturers and sellers of these medical products, requiring them to ensure their items contain no intentionally added PFAS or PFAS above a feasible, regularly reviewed threshold. Sellers must obtain written compliance certificates from manufacturers confirming PFAS-free products, and violations carry civil penalties up to $2,500 per day of noncompliance. The law focuses on concrete regulatory changes for medical products, excluding FDA-regulated devices from its scope.
Relates to the provision of patient health information and medical records; expands the definition of medical records to include all health related records; prohibits fees for providing certain records.
Develops comprehensive assessment centers for autism spectrum disorders; provides grants for their development and lays out reporting and research requirements.
Requires any sponsor of a clinical trial in this state, including but not limited to, a pharmaceutical drug manufacturer, pharmaceutical drug wholesaler, academic medical center, voluntary group, federal agency or health care provider, that applies for a state grant to conduct such clinical trial, to conspicuously post certain information about such clinical trial on the department's website.
S 2206 prohibits hospitals and transplant centers from denying organ transplants or related services solely due to a person's physical or mental disability. It requires covered entities (like hospitals and transplant programs) to make reasonable accommodations - such as involving support networks or using accessible communication methods - to ensure individuals with disabilities can access transplants. The bill explicitly bans discrimination in listing patients on waiting lists, referrals, or insurance coverage for transplant-related care. It aligns with the Americans with Disabilities Act by requiring individualized medical evaluations rather than assumptions about disability. This law directly affects New York residents with disabilities who need organ transplants, ensuring they receive fair consideration based on medical suitability, not disability status.
This bill requires New York's health department to create and operate a free mobile application for individuals eligible for Medicaid who are pregnant, postpartum, or planning pregnancy. The app must provide New York-specific resources, links to state programs, and support in multiple languages, with strict privacy protections prohibiting personal data sharing. Developers must report anonymized usage data (like user numbers and engagement) to state lawmakers. The app will be available across mobile platforms and must comply with state health resource standards.
Requires coverage for colorectal cancer early detection beginning at age thirty-five; adds coverage for colorectal cancer early detection as a required coverage for individual policies; requires notification of colorectal early detection coverage to be provided to insured individuals beginning at age thirty-five.
Provides lifetime, premium-free insurance through the New York state of health marketplace to a person who donates a kidney during the course of their lifetime; establishes the kidney donor insurance fund.
Requires any information or data produced internally or by an outside consultant used by the governor, the division of the budget, the department of health or any other relevant state agency to justify such reduction be made available to elected officials prior to funding reductions for hospitals and nursing homes.
